These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17577029)

  • 1. Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.
    Griggs JJ; Culakova E; Sorbero ME; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
    J Clin Oncol; 2007 Jun; 25(18):2522-7. PubMed ID: 17577029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.
    Griggs JJ; Culakova E; Sorbero ME; van Ryn M; Poniewierski MS; Wolff DA; Crawford J; Dale DC; Lyman GH
    J Clin Oncol; 2007 Jan; 25(3):277-84. PubMed ID: 17159190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.
    Wu XC; Lund MJ; Kimmick GG; Richardson LC; Sabatino SA; Chen VW; Fleming ST; Morris CR; Huang B; Trentham-Dietz A; Lipscomb J
    J Clin Oncol; 2012 Jan; 30(2):142-50. PubMed ID: 22147735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
    DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
    Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne M; Crawford J; Dale DC; Culakova E; Lyman GH;
    Breast Cancer Res Treat; 2006 Dec; 100(3):255-62. PubMed ID: 16705366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.
    Lyman GH; Dale DC; Crawford J
    J Clin Oncol; 2003 Dec; 21(24):4524-31. PubMed ID: 14673039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer treatment guidelines in older women.
    Giordano SH; Hortobagyi GN; Kau SW; Theriault RL; Bondy ML
    J Clin Oncol; 2005 Feb; 23(4):783-91. PubMed ID: 15681522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
    Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
    J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.
    Courneya KS; McKenzie DC; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; Segal RJ
    Cancer; 2008 Apr; 112(8):1845-53. PubMed ID: 18306372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
    Buijs C; Rodenhuis S; Seynaeve CM; van Hoesel QG; van der Wall E; Smit WJ; Nooij MA; Voest E; Hupperets P; TenVergert EM; van Tinteren H; Willemse PH; Mourits MJ; Aaronson NK; Post WJ; de Vries EG
    J Clin Oncol; 2007 Dec; 25(34):5403-9. PubMed ID: 18048822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
    Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA
    J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
    Cheung WY; Neville BA; Earle CC
    Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?
    Woodard S; Nadella PC; Kotur L; Wilson J; Burak WE; Shapiro CL
    Cancer; 2003 Sep; 98(6):1141-9. PubMed ID: 12973837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
    Hawfield A; Lovato J; Covington D; Kimmick G
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?].
    Kroman NT; Jensen MB; Wohlfahrt J; Mouridsen H; Andersen PK; Melbye M
    Ugeskr Laeger; 2000 May; 162(22):3184-8. PubMed ID: 10850209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
    Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
    Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
    J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
    Kuo SH; Lien HC; You SL; Lu YS; Lin CH; Chen TZ; Huang CS
    Breast; 2008 Dec; 17(6):646-53. PubMed ID: 18595699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.